The Path from LifestyleRx

Osteoarthritis Isn’t Wear and Tear | Dr. Maziar Badii

The Path from LifestyleRx

Show Notes

About the Episode For years, osteoarthritis was blamed on simple wear and tear, but new research points to inflammation and metabolic health as major drivers of joint pain. Dr. Maziar Badii explains how osteoarthritis is diagnosed, why weight loss and food choices can ease joint pain, and why exercise, even running, is rarely off limits. You will also hear how treatment works, from creams and pills to injections and joint replacement.

About the Guest Dr. Maziar Badii is a rheumatologist in the Division of Rheumatology at the University of British Columbia, with a cross appointment in Radiology. He has practiced rheumatology for 25 years, is a past president of the Northwest Rheumatism Society, and received the 2023 Polaris Award for Innovation in Rheumatology.

About The Path Podcast

The Path is about simple strategies for better metabolic health. We break down metabolic disease, prediabetes, and type 2 diabetes through patient FAQs, better health decisions, and honest interviews with patients and the physicians who treat them.

Learn More About LifestyleRx: https://lifestylerx.io/

Ask us a video question! https://ask-a-question.lifestylerx.ca

Episode 122 | The Path Podcast

More from The Path from LifestyleRx

Oct 15, 2026

About the Episode As part of our late summer break, we're revisiting one of our favorite conversations from The Path archive. Most of us lose muscle as we age, and the tiny engines inside our cells, called mitochondria, get weaker too, which feeds insulin resistance and type 2 diabetes. In this episode, Dr. Mark Tarnopolsky explains how exercise, protein, and colorful foods help protect both, and why strength and endurance training each matter. He also shares how to check supplement claims, including a protein blend from his own company.

Oct 8, 2026

About the Episode You can develop serious liver scarring without ever drinking alcohol. Liver specialist Dr. Alnoor Ramji explains why fat in the liver deserves attention, how it connects to insulin resistance and type 2 diabetes, and which simple yearly blood test can flag liver damage early. You'll also learn which food and activity changes help, and why the liver has a strong ability to heal.

Oct 1, 2026

About the Episode Type 2 diabetes does not start when blood sugar rises. It starts years earlier, in the small cells of the pancreas that make insulin. Dr. Brendan Byrne talks with diabetes researcher Dr. Jim Johnson about whether too much insulin can come before insulin resistance, why many of these cells are tired rather than gone, and how rest, food choices, and exercise may help them recover.

Sep 24, 2026

About the Episode Some people diagnosed with type 2 diabetes have a slow, autoimmune form of diabetes called LADA, where the immune system attacks the cells that make insulin. Dr. Brendan Byrne and endocrinologist Dr. Tom Elliott explain how antibody testing works, what the newly approved drug teplizumab can and can't do, and why very low doses of Ozempic may help protect insulin-making cells. They also look ahead at the treatments that could arrive in the next five to ten years.

Sep 17, 2026

About the Episode As part of our late summer break, we're revisiting one of our favorite conversations from The Path archive. Gordo Byrn went from out of shape in his twenties to winning the Ultraman World Championship, and along the way he learned that the same habits that build elite athletes can help anyone turn their health around, even with a family history stacked against them. In this episode, Gordo breaks down the framework he uses with everyday people: how to build an exercise habit that actually sticks, why easy pace often feels the hardest part of training, and the simple blood pressure trick that helped his own dad lose sixty pounds for good.

See all episodes →